title: Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
authors.affiliation: Department of Neurology, Mayo Clinic Arizona, 5777 E. Mayo Blvd., Phoenix, AZ 85054, USA. Dodick.David@mayo.edu
authors.forename: David W
authors.initials: DW
authors.lastname: Dodick
authors.forename: James
authors.initials: J
authors.lastname: Kost
authors.forename: Christopher
authors.initials: C
authors.lastname: Assaid
authors.forename: Christopher
authors.initials: C
authors.lastname: Lines
authors.forename: Tony W
authors.initials: TW
authors.lastname: Ho